Literature DB >> 27084518

The role of autophagy in cardiac hypertrophy.

Lanfang Li1, Jin Xu2, Lu He2, Lijun Peng1, Qiaoqing Zhong3, Linxi Chen4, Zhisheng Jiang5.   

Abstract

Autophagy is conserved in nature from lower eukaryotes to mammals and is an important self-cannibalizing, degradative process that contributes to the elimination of superfluous materials. Cardiac hypertrophy is primarily characterized by excess protein synthesis, increased cardiomyocyte size, and thickened ventricular walls and is a major risk factor that promotes arrhythmia and heart failure. In recent years, cardiomyocyte autophagy has been considered to play a role in controlling the hypertrophic response. However, the beneficial or aggravating role of cardiomyocyte autophagy in cardiac hypertrophy remains controversial. The exact mechanism of cardiomyocyte autophagy in cardiac hypertrophy requires further study. In this review, we summarize the controversies associated with autophagy in cardiac hypertrophy and provide insights into the role of autophagy in the development of cardiac hypertrophy. We conclude that future studies should emphasize the relationship between autophagy and the different stages of cardiac hypertrophy, as well as the autophagic flux and selective autophagy. Autophagy will be a potential therapeutic target for cardiac hypertrophy.
© The Author 2016. Published by Oxford University Press on behalf of the Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  autophagic flux; autophagy; cardiac function; cardiac hypertrophy; cell signaling

Mesh:

Year:  2016        PMID: 27084518      PMCID: PMC4913516          DOI: 10.1093/abbs/gmw025

Source DB:  PubMed          Journal:  Acta Biochim Biophys Sin (Shanghai)        ISSN: 1672-9145            Impact factor:   3.848


  114 in total

Review 1.  Ubiquitination and selective autophagy.

Authors:  S Shaid; C H Brandts; H Serve; I Dikic
Journal:  Cell Death Differ       Date:  2012-06-22       Impact factor: 15.828

2.  Valsartan regulates myocardial autophagy and mitochondrial turnover in experimental hypertension.

Authors:  Xin Zhang; Zi-Lun Li; John A Crane; Kyra L Jordan; Aditya S Pawar; Stephen C Textor; Amir Lerman; Lilach O Lerman
Journal:  Hypertension       Date:  2014-04-21       Impact factor: 10.190

Review 3.  Striking a balance: autophagy, apoptosis, and necrosis in a normal and failing heart.

Authors:  Wajihah Mughal; Rimpy Dhingra; Lorrie A Kirshenbaum
Journal:  Curr Hypertens Rep       Date:  2012-12       Impact factor: 5.369

Review 4.  Unmasking the janus faces of autophagy in obesity-associated insulin resistance and cardiac dysfunction.

Authors:  Xihui Xu; Jun Ren
Journal:  Clin Exp Pharmacol Physiol       Date:  2012-02       Impact factor: 2.557

Review 5.  AMPK: energy sensor and survival mechanism in the ischemic heart.

Authors:  Dake Qi; Lawrence H Young
Journal:  Trends Endocrinol Metab       Date:  2015-07-06       Impact factor: 12.015

Review 6.  Autophagy, redox signaling, and ventricular remodeling.

Authors:  Narasimman Gurusamy; Dipak K Das
Journal:  Antioxid Redox Signal       Date:  2009-08       Impact factor: 8.401

7.  Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.

Authors:  Julie R McMullen; Megan C Sherwood; Oleg Tarnavski; Li Zhang; Adam L Dorfman; Tetsuo Shioi; Seigo Izumo
Journal:  Circulation       Date:  2004-06-07       Impact factor: 29.690

8.  miR-30a downregulation aggravates pressure overload-induced cardiomyocyte hypertrophy.

Authors:  Xuesong Yin; Chenghai Peng; Wenhu Ning; Chunyan Li; Zhongqiao Ren; Jihong Zhang; Han Gao; Kan Zhao
Journal:  Mol Cell Biochem       Date:  2013-05-10       Impact factor: 3.396

9.  Chloroquine prevents progression of experimental pulmonary hypertension via inhibition of autophagy and lysosomal bone morphogenetic protein type II receptor degradation.

Authors:  Lu Long; Xudong Yang; Mark Southwood; Junyu Lu; Stefan J Marciniak; Benjamin J Dunmore; Nicholas W Morrell
Journal:  Circ Res       Date:  2013-02-27       Impact factor: 17.367

10.  Autophagy plays an essential role in mediating regression of hypertrophy during unloading of the heart.

Authors:  Nirmala Hariharan; Yoshiyuki Ikeda; Chull Hong; Ralph R Alcendor; Soichiro Usui; Shumin Gao; Yasuhiro Maejima; Junichi Sadoshima
Journal:  PLoS One       Date:  2013-01-07       Impact factor: 3.240

View more
  24 in total

1.  [Fucoxanthin regulates Nrf2/Keap1 signaling to alleviate myocardial hypertrophy in diabetic rats].

Authors:  D Zheng; L Chen; Q Wei; Z Zhu; Z Liu; L Jin; G Yang; X Xie
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-05-20

2.  Harmine is an effective therapeutic small molecule for the treatment of cardiac hypertrophy.

Authors:  Jie Huang; Yang Liu; Jia-Xin Chen; Xin-Ya Lu; Wen-Jia Zhu; Le Qin; Zi-Xuan Xun; Qiu-Yi Zheng; Er-Min Li; Ning Sun; Chen Xu; Hai-Yan Chen
Journal:  Acta Pharmacol Sin       Date:  2021-03-30       Impact factor: 7.169

3.  Inhibition of lncRNA Gm15834 Attenuates Autophagy-Mediated Myocardial Hypertrophy via the miR-30b-3p/ULK1 Axis in Mice.

Authors:  Chao Song; Hanping Qi; Yongsheng Liu; Yunping Chen; Pilong Shi; Shu Zhang; Jing Ren; Lixin Wang; Yonggang Cao; Hongli Sun
Journal:  Mol Ther       Date:  2020-10-31       Impact factor: 11.454

4.  DanHong injection targets endothelin receptor type B and angiotensin II receptor type 1 in protection against cardiac hypertrophy.

Authors:  Min-Yu Zhang; Fei-Fei Guo; Hong-Wei Wu; Yang-Yang Yu; Jun-Ying Wei; Shi-Feng Wang; Yu-Xin Zhang; Ming-Hua Xian; Qing-Hua Wu; Bu-Chang Zhao; Shi-You Li; Hong-Jun Yang
Journal:  Oncotarget       Date:  2017-10-13

Review 5.  Macroautophagy and Chaperone-Mediated Autophagy in Heart Failure: The Known and the Unknown.

Authors:  Rajeshwary Ghosh; J Scott Pattison
Journal:  Oxid Med Cell Longev       Date:  2018-01-18       Impact factor: 6.543

6.  Estrogen and/or Estrogen Receptor α Inhibits BNIP3-Induced Apoptosis and Autophagy in H9c2 Cardiomyoblast Cells.

Authors:  Bih-Cheng Chen; Yi-Jiun Weng; Marthandam Asokan Shibu; Chien-Kuo Han; Yueh-Sheng Chen; Chia-Yao Shen; Yueh-Min Lin; Vijaya Padma Viswanadha; Hsin-Yueh Liang; Chih-Yang Huang
Journal:  Int J Mol Sci       Date:  2018-04-26       Impact factor: 5.923

7.  TET1 exerts its tumour suppressor function by regulating autophagy in glioma cells.

Authors:  Rui Fu; Yan Ding; Jie Luo; Li Yu; Cheng Lin Li; Dong Sheng Li; Shi Wen Guo
Journal:  Biosci Rep       Date:  2017-11-06       Impact factor: 3.840

8.  MiR-100-5p regulates cardiac hypertrophy through activation of autophagy by targeting mTOR.

Authors:  Junyi Zeng; Liang Wang; Jianqing Zhao; Zeqi Zheng; Jingtian Peng; Wan Zhang; Tong Wen; Jungang Nie; Lu Ding; Dasong Yi
Journal:  Hum Cell       Date:  2021-06-17       Impact factor: 4.174

Review 9.  Emergence of Members of TRAF and DUB of Ubiquitin Proteasome System in the Regulation of Hypertrophic Cardiomyopathy.

Authors:  Ishita Gupta; Nishant K Varshney; Sameena Khan
Journal:  Front Genet       Date:  2018-08-21       Impact factor: 4.599

10.  Si-Miao-Yong-An Decoction Maintains the Cardiac Function and Protects Cardiomyocytes from Myocardial Ischemia and Reperfusion Injury.

Authors:  Wenwen Cui; Shen Xin; Lingjuan Zhu; Mingye Wang; Yuanyuan Hao; Yuqian Zhao; Yang Li; Yunlong Hou
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-26       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.